Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-04

FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for cilostazol from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)